Actavis Pharmaceuticals Warned for Laser Drill Deficiencies

Drug Industry Daily
A A
Teva subsidiary Actavis Pharmaceuticals drew a warning letter from the FDA for laser-drilled tablet manufacturing at its Davie, Florida facility.

To View This Article:

Login

Subscribe To Drug Industry Daily